Our recent study found that a derivative of a natural product called schweinfurthins dramatically improves anti-PD-1 checkpoint therapy of melanoma. Read the article here: https://www.tandfonline.com/doi/full/10.1080/2162402X.2018.1539614
Katie Kokolus’ recent work suggests that beta blockers may improve overall survival for metastatic melanoma patients treated with immunotherapy. Read the story here:http://news.psu.edu/story/497450/2018/01/08/research/beta-blockers-may-boost-immunotherapy-help-melanoma-patients-live